A gut feeling about thrombosis

New England Journal of Medicine

Volumn 374, Issue 25, 2016, Pages 2494-2496

  Tilg, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; METHYLAMINE; PLASMALOGEN; TRIMETHYLOXAMINE;

ATHEROSCLEROSIS; CORRELATIONAL STUDY; DISEASE ASSOCIATION; HUMAN; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SHEAR STRESS; SHORT SURVEY; THROMBOCYTE ACTIVATION; THROMBOSIS; ANIMAL; BLOOD; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CHOLINE; GASTROINTESTINAL MICROBIOME; HUMANS; METHYLAMINES; MICE; PLASMALOGENS; RISK FACTORS; THROMBOSIS;

EID: 84975475449     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr1604458     Document Type: Short Survey

References (5)

1. Tang WHW, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013;368:1575-84.
2. Zhu W, Gregory JC, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 2016;165:111-24.
3. Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 2015;163:1585-95.
4. Miao J, Ling AV, Manthena PV, et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat Commun 2015;6:6498.
5. Warrier M, Shih DM, Burrows AC, et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep 2015 January 14 (Epub ahead of print).